Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Lower Risk of Incident Cataracts and Diabetic Retinopathy amongst Individuals Treated with Sodium Glucose Cotransporter-2 Inhibitor Compared to Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Mellitus

Li Yen Goh, Oscar Hou In Chou, Sharen Lee, Teddy Tai Loy Lee, Jeremy Man To Hui, Hugo Pui Hok Him, Wing Tak Wong, Carlin Chang, Bernard Man Yung Cheung, View ORCID ProfileGary Tse, View ORCID ProfileJiandong Zhou
doi: https://doi.org/10.1101/2024.03.25.24304828
Li Yen Goh
1Department of Ophthalmology, King’s College Hospital NHS Trust, London, United Kingdom
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
BMedSci BMBS FRCOphth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar Hou In Chou
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
8Division of Clinical Pharmacology and Therapeutics, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharen Lee
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teddy Tai Loy Lee
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
BPharm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Man To Hui
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo Pui Hok Him
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wing Tak Wong
3School of Life Sciences, Chinese University of Hong Kong, Hong Kong, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlin Chang
4Department of Medicine, Queen Mary Hospital, Hong Kong, China
MPhil MRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Man Yung Cheung
8Division of Clinical Pharmacology and Therapeutics, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
MB BChir FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Tse
2Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China
5Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
6Kent and Medway Medical School, Canterbury, United Kingdom
7School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China
MD PhD FRCP FFPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gary Tse
  • For correspondence: gary.tse{at}kmms.ac.uk jiandong.zhou{at}warwick.ac.uk
Jiandong Zhou
9Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
10Division of Health Sciences, Warwick Medical School, University of Warwick, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jiandong Zhou
  • For correspondence: gary.tse{at}kmms.ac.uk jiandong.zhou{at}warwick.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: March 2024 to June 2025

AbstractFullPdf
Mar 2024178831
Apr 2024101618
May 202480721
Jun 2024531015
Jul 202449224
Aug 202419313
Sep 202447721
Oct 20241959
Nov 20241616
Dec 20241418
Jan 202538111
Feb 202526219
Mar 2025392421
Apr 202543222
May 202557811
Jun 2025807
Back to top
PreviousNext
Posted March 27, 2024.
Download PDF
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Lower Risk of Incident Cataracts and Diabetic Retinopathy amongst Individuals Treated with Sodium Glucose Cotransporter-2 Inhibitor Compared to Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Mellitus
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lower Risk of Incident Cataracts and Diabetic Retinopathy amongst Individuals Treated with Sodium Glucose Cotransporter-2 Inhibitor Compared to Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Mellitus
Li Yen Goh, Oscar Hou In Chou, Sharen Lee, Teddy Tai Loy Lee, Jeremy Man To Hui, Hugo Pui Hok Him, Wing Tak Wong, Carlin Chang, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou
medRxiv 2024.03.25.24304828; doi: https://doi.org/10.1101/2024.03.25.24304828
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Lower Risk of Incident Cataracts and Diabetic Retinopathy amongst Individuals Treated with Sodium Glucose Cotransporter-2 Inhibitor Compared to Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Mellitus
Li Yen Goh, Oscar Hou In Chou, Sharen Lee, Teddy Tai Loy Lee, Jeremy Man To Hui, Hugo Pui Hok Him, Wing Tak Wong, Carlin Chang, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou
medRxiv 2024.03.25.24304828; doi: https://doi.org/10.1101/2024.03.25.24304828

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)